Analysis of Nevirapine (NVP) Resistance in Ugandan Infants Who Were HIV Infected Despite Receiving Single-Dose (SD) NVP versus SD NVP Plus Daily NVP Up to 6 Weeks of Age to Prevent HIV Vertical Transmission

This publication has 22 references indexed in Scilit:

• Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention
  AIDS, 2007
• Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments
  American Journal of Obstetrics and Gynecology, 2007
• Drug Resistance in Plasma and Breast Milk after Single-Dose Nevirapine in Subtype C HIV Type 1: Population and Clonal Sequence Analysis
  AIDS Research and Human Retroviruses, 2007
• Late Postnatal Transmission of HIV‐1 and Associated Factors
  The Journal of Infectious Diseases, 2007
• Emergence of NNRTI Drug Resistance Mutations after Single-Dose Nevirapine Exposure in HIV Type 1 Subtype C-Infected Infants in India
  AIDS Research and Human Retroviruses, 2007
• Sensitivity of the ViroSeq HIV-1 Genotyping System for Detection of the K103N Resistance Mutation in HIV-1 Subtypes A, C, and D
  The Journal of Molecular Diagnostics, 2006
• Breast‐Milk Shedding of Drug‐Resistant HIV‐1 Subtype C in Women Exposed to Single‐Dose Nevirapine
  The Journal of Infectious Diseases, 2005
• Association of Levels of HIV‐1–Infected Breast Milk Cells and Risk of Mother‐to‐Child Transmission
  The Journal of Infectious Diseases, 2004
• Intrapartum Exposure to Nevirapine and Subsequent Maternal Responses to Nevirapine-Based Antiretroviral Therapy
  New England Journal of Medicine, 2004
• Correlates of Mother‐to‐Child Human Immunodeficiency Virus Type 1 (HIV‐1) Transmission: Association with Maternal Plasma HIV‐1 RNA Load, Genital HIV‐1 DNA Shedding, and Breast Infections
  The Journal of Infectious Diseases, 2001